TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
LRMR

Larimar Therapeutics Inc

Healthcare · Biotechnology

3.80$ -3.3% vs. previous close Closing price · As of: Sep 17, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Larimar Therapeutics Inc (LRMR) with date, type and a link to the original document.

Filings LRMR
Date Type Filing Original
08/04/2026 Current report (8-K) Larimar Therapeutics, Inc. (LRMR): Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?